Depo-SubQ Provera 104 needs to be given by subcutaneous (hypodermic) injection once every 12 weeks. This is not an intramuscular injection and must be given by someone trained and knowledgeable on how to give a subcutaneous injection.
The main active ingredient in Depo-SubQ Provera 104 is Medroxyprogesterone acetate 104 mg.
The risks are low, but some women experience side effects when using Depo-SubQ Provera 104. Minor ones include (spotting) or some gain weight. Positive side effects are also a possibility, too — lighter bleeds are fairly common.
The chances of serious side effects from birth control pills are extremely unlikely, but some cases have been documented, such as unexplained vaginal bleeding, severe pelvic pain, severe abdominal pain, and bone pain. Depo-SubQ 104 has been associated with lower bone mineral density (BMD). However, pregnancy results in a greater potential loss of BMD. This method is not recommended for younger patients who have not yet reached their peak bone mass or patients with osteoporosis. Alternatives to Depo-SubQ Provera would be the pill, patch, ring.
If you experience swelling/itching of your face/throat/tongue, trouble breathing, or severe dizziness, this may indicate an allergic reaction, please call 911 or get to the emergency room to receive appropriate emergency medical treatment.
Do NOT take this medication if:
Do not have an intact uterus, or is pregnant, or have a history of bleeding disorders, uterus dispermness, or perforation of the small intestines. This is because they result in a heavy, heavy, or oily sex hormones that could be harmful. Also, if you have had a heart attack, stroke, or heart surgery with a thromboembolic index (RABI) of at least 100 mL/min or more, you may be at an increased risk for cardiovascular events, such as heart failure, stroke, or hypertension. Depo-SubQ Provera should not be used in patients with a history of pulmonary embolism (PE), deep vein thrombosis (DVT), or pulmonary thromboembolic disease (PEDT). In patients with a history of deep vein thrombosis (DVT) or pulmonary embolism (PE), this medication could increase the risk of leg pain. Also, this medication could cause anesthetic agents to surge in blood pressure that are potentially dangerous. Many other medications contain medroxyprogesterone acetate, which can increase the risk of side effects.Also, do not take this medication with any other products such as blood clot or other medications that reduce estrogen.All the side effects listed above may occur when the hormones are not absorbed and are not taken into account by those taking this medication. Additionally, there is a risk of increased suicidal thoughts and behaviors with this medication. This side effect is rare — very rare — and there is no way to know if you have any if any problems. Depo-SubQ 104 has been associated with increased risk of multiple psychiatric and allergic adverse effects.
The risks of getting these medications right while using Depo-SubQ Provera 104 are similar to those seen with other medications used to treat infertility, including some that are used to reduce sperm count and motility. While you are taking Depo-SubQ 104, your doctor will do lab tests to find any abnormalities you might be experiencing. If you are having these lab tests, your doctor will perform a examination using a blood pressureeter to find any abnormalities you might be experiencing.
If you are experiencing any lab tests that show worsening depression,algamidol, or anxiety, these could be signs of a first sign you are taking Depo-SubQ 104 and want to know as well as possible. Also, these tests can help rule out systemic or bacterial causes and would be best treated with an implantable anti-depressant. Your doctor will perform an aloglicitant blood and bone density test to find any underlying medical conditions you may have or would like such that warrant a checkup. Depo-SubQ 104 is also used to reduce the risk of blood clots in certain cancers.
Sexual health is a crucial aspect of overall well-being, especially for those who have sex.
Many men and women on prescription medications find that taking their medication optimizes their sexual health and relationships by making it easier for them to have and maintain intimate relationships.
Here are some key points to know about Sexual Health:
You can also find more information about the topic below:
You can take your Medroxyprogesterone with or without food. It’s important to follow your healthcare provider’s guidance on the correct dosage and frequency of use.
Common side effects of Medroxyprogesterone may include headache, nausea, vomiting, stomach pain, and breast tenderness. If any of these effects persist or worsen, consult your healthcare provider immediately.
It’s important to note that not everyone will experience these side effects. If you do experience these side effects, discuss with your healthcare provider for guidance on managing them effectively.
Yes, Medroxyprogesterone can be taken by and for women. This medication helps regulate blood sugar levels and may decrease the risk of certain cancers. If you do, discuss with your healthcare provider for guidance on managing these risks.
Medroxyprogesterone is an effective treatment for weight management in those with type 2 diabetes. It works by reducing the amount of insulin produced in the body. By reducing the amount of insulin produced by the body, Medroxyprogesterone helps to weight loss.
Yes, Medroxyprogesterone can be taken by children.
Take your Medroxyprogesterone with or without food, typically as prescribed by your healthcare provider. Follow your healthcare provider’s instructions on the dosage and schedule of use.
Yes, Medroxyprogesterone may be different from other reproductive health products. It’s important to be aware of the potential side effects and consult your healthcare provider for personalized guidance.
Medroxyprogesterone can cause various side effects, but the most common ones are usually mild and short-lived. These may include breast tenderness, headache, muscle pain, nausea, and fluid retention. If you experience any severe side effects, seek medical attention immediately.
It’s important to report side effects to your healthcare provider, and share them with your family or friends.
Yes, Medroxyprogesterone can be taken by women.
The efficacy of medroxyprogesterone acetate (MPA) is dependent on a comprehensive understanding of its effects on the brain, and the possible impact of MPA on mood and behaviour. The aim of this study was to assess the effects of combined administration of MPA-containing birth control and medroxyprogesterone acetate (MPA-DMPA) on mood and behaviour in rats. A total of 90,639 rats were randomly divided into three groups: the combined MPA-DMPA, combined MPA-PA, and vehicle group. The results of the exploratory behavior test showed significant reduction in behaviour in the combined MPA-DMPA group (p<0.01), as well as reduced stress and heavy drinking behavior in the combined MPA-PA group (p<0.05). Moreover, MPA administration in combination with MPA-DMPA resulted in a decrease in the frequency of grooming behaviour in both the combined MPA-DMPA group and the vehicle group. In conclusion, the combined administration of MPA-DMPA and medroxyprogesterone acetate (MPA-DMPA) can attenuate the effects of combined MPA on behaviour in rats with both a low and high dose of MPA. Based on these findings, the combined administration of MPA-DMPA and MPA-PA may help to reduce the excessive stress and heavy drinking in both the combined MPA-DMPA and the vehicle rats. The combined administration of MPA-DMPA and MPA-PA may also have benefits in reducing the heavy drinking behavior of both the combined MPA-DMPA and the vehicle rats.
Pregnancy outcomes of the combined MPA-DMPA (MPA-DMPA), combined MPA-PA (PA), and vehicle groups on fertility parameters in rats.The effects of MPA on fertility of rats have been previously described [
]. MPA is a synthetic progesterone that is known to regulate the female reproductive system, including the ovaries and endometrium. MPA is widely used as a contraceptive, which has a significant impact on female fertility. The use of MPA-DMPA in female rats is associated with an increased risk of spontaneous abortions and other health problems [
The aim of this study was to assess the effects of combined administration of MPA-DMPA and MPA-PA on fertility of rats.
Materials and methods
Male Wistar rats (60–80 g) were used in this study. The rats were kept in a clean and controlled room at 22–30 °C and 5% relative humidity. The rats were divided into three groups: vehicle, combined MPA-DMPA, and combined MPA-PA. The rats were divided into three groups: the vehicle and combined MPA-DMPA, and the combined MPA-PA. The animals were fed food and water ad libitum. The study was approved by the Animal Experiment Ethics Committee of Guangzhou University (Approval No. ZY-2015-038).In this study, rats were weighed at baseline and 3,926 days after the last injection of MPA (25 mg/kg) and MPA-DMPA at 3,926 days after the last injection of MPA (100 mg/kg) were randomly given to each rat. The rats were given an intraperitoneal (i.p.) injection of medroxyprogesterone acetate (MPA-DMPA) orally for 3 days. The rats were sacrificed 3,926 days after the last i.p. injection. Blood samples were collected for analysis of hormone and fertility parameters. The rats were anesthetized with sodium pentobarbital (100 mg/kg, ip) and sacrificed in order to induce ovulation. MPA-DMPA, combined MPA-PA, and vehicle groups were administrated i.p. at doses of 25, 50, and 100 mg/kg orally for 3 days, and the mice were anesthetized with 10% pentobarbital (100 mg/kg) and sacrificed in order to induce ovulation. All the rats were weighed 3,926 days after the last i.p. injection of MPA-DMPA and the mice were anesthetized with 10% pentobarbital (100 mg/kg) and sacrificed in order to induce ovulation. at doses of 25, 50, and 100 mg/kg orally for 3 days.
Buy Provera 5 mg (Provera) 20 Tablets online
We only sell the best quality products in our shop.
Product Details:
| Product Name | Provera |
| Manufacturer | Bausch Health |
| Packaging Size | 10 tablets in strip |
| Form | Tablets |
| Packaging Type | Box |
| Composition | Provera 5 mg |
| Country of Origin | Made in India |
Male Pattern Baldness is the most popular and profitable type of cancer. This type of cancer can cause a great pain in men and women all over the world. This type of cancer can be cured by Provera, a medicine used for the treatment of this cancer.
Provera is manufactured by Sunrise Pharmaceuticals Ltd, one of the leading pharmaceutical companies globally. Sunrise has a dedicated team of experts who are highly skilled in the manufacture of prescription and over-the-counter medicines.
The product is available at most pharmacies in India. If you want to get your medicine at a cheaper price, then you can get the product in our online shop.
Additional Information:
We are a trusted online pharmacy in India and we sell best quality products.
Buy Provera 5 mg (Provera) 20 Tablets OnlineBuy Provera 5 mg (Provera) 20 Tablets online from our store.
All you need is to complete the online payment and the price will be delivered right to your home. The price of Provera 5 mg (Provera) 5 Tablets is Rs. 550.00. The delivery time is 5 to 10 days.
Depo-Provera (medroxyprogesterone acetate) injection(Depo-Provera® injection) is a hormone replacement therapy (HRT) that helps regulate the menstrual cycle. It reduces the number of the pituitary gland cells that produce and release folliclestimulating hormone (FSH) and luteinizing hormone (LH). It is administered every three to six months and can be continued for up to one year to prevent pregnancy. Injection is injected into the pellet every six months. It is usually administered for one to four weeks to promote the growth of the ovaries. If pregnancy does not occur, Depo-Provera is stopped and the shot is stopped.
Depo-Provera is available in both injectable and non-injectable forms. Non-injectable forms include:
Non-injectable Depo-Provera is administered every three to six months. Non-injectable Depo-Provera is administered every six months to prevent pregnancy.
Injectable Depo-Provera is administered every six months. Injectable Depo-Provera is administered every three to six months. Injectable Depo-Provera is administered every six months to prevent pregnancy.
Stade de France Pharmacy